China Medical System Holdings Ltd CHSYF의 지난 분기 매출 실적은 어땠나요?
China Medical System Holdings Ltd의 매출 추정치는 얼마인가요?
China Medical System Holdings Ltd의 수익 품질 점수는 얼마인가요?
China Medical System Holdings Ltd는 언제 수익을 보고하나요?
China Medical System Holdings Ltd의 예상 수익은 얼마인가요?
China Medical System Holdings Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1.35
시가
$0.9307
일일 범위
$0.9307 - $0.9307
52주 범위
$0.9307 - $1.63
거래량
110
평균 거래량
0
EPS(TTM)
0.10
배당수익률
--
시가총액
$2.2B
CHSYF란 무엇인가요?
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,095 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.